Literature DB >> 10095778

Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins.

L Stanasila1, D Massotte, B L Kieffer, F Pattus.   

Abstract

Human opioid receptors of the delta, mu and kappa subtypes were successfully expressed in Escherichia coli as fusions to the C-terminus of the periplasmic maltose-binding protein, MBP. Expression levels of correctly folded receptor molecules were comparable for the three subtypes and reached an average of 30 receptors.cell-1 or 0.5 pmol.mg-1 membrane protein. Binding of [3H]diprenorphine to intact cells or membrane preparations was saturatable, with a dissociation constant, KD, of 2.5 nM, 0.66 nM and 0.75 nM for human delta, mu and kappa opioid receptors (hDOR, hMOR and hKOR, respectively). Recombinant receptors of the three subtypes retained selectivity and nanomolar affinity for their specific antagonists. Agonist affinities were decreased by one to three orders of magnitude as compared to values measured for receptors expressed in mammalian cells. The effect of sodium on agonist binding to E. coli-expressed receptors was investigated. Receptor high-affinity state for agonists was reconstituted in the presence of heterotrimeric G proteins. We also report affinity values of endomorphins 1 and 2 for mu opioid receptors expressed both in E. coli and in COS cells. Our results confirm that opioid receptors can be expressed in a functional form in bacteria and point out the advantages of E. coli as an expression system for pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10095778     DOI: 10.1046/j.1432-1327.1999.00187.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Large-scale expression and purification of a G-protein-coupled receptor for structure determination -- an overview.

Authors:  Reinhard Grisshammer; Jim F White; Loc B Trinh; Joseph Shiloach
Journal:  J Struct Funct Genomics       Date:  2005

2.  Expression of membrane proteins from Mycobacterium tuberculosis in Escherichia coli as fusions with maltose binding protein.

Authors:  A Korepanova; J D Moore; H B Nguyen; Y Hua; T A Cross; F Gao
Journal:  Protein Expr Purif       Date:  2006-12-24       Impact factor: 1.650

3.  Using EGFP fusions to monitor the functional expression of GPCRs in the Drosophila Schneider 2 cells.

Authors:  Karl Brillet; Bénédicte G Perret; Valérie Klein; Franc Pattus; Renaud Wagner
Journal:  Cytotechnology       Date:  2008-01-19       Impact factor: 2.058

4.  A systematic assessment of mature MBP in membrane protein production: overexpression, membrane targeting and purification.

Authors:  Jian Hu; Huajun Qin; Fei Philip Gao; Timothy A Cross
Journal:  Protein Expr Purif       Date:  2011-06-13       Impact factor: 1.650

5.  Membrane Protein Production and Purification from Escherichia coli and Sf9 Insect Cells.

Authors:  Yixin Liu; Ana Pavić; Joshua T Farley; Carine de Marcos Lousa; Adrian Goldman; Vincent L G Postis
Journal:  Methods Mol Biol       Date:  2020

Review 6.  Tolerance to changes in membrane lipid composition as a selected trait of membrane proteins.

Authors:  Charles R Sanders; Kathleen F Mittendorf
Journal:  Biochemistry       Date:  2011-08-24       Impact factor: 3.162

Review 7.  Crystal structures of fusion proteins with large-affinity tags.

Authors:  Douglas R Smyth; Marek K Mrozkiewicz; William J McGrath; Pawel Listwan; Bostjan Kobe
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

8.  Characterization of an engineered water-soluble variant of the full-length human mu opioid receptor.

Authors:  Jin Xi; Jie Xiao; Jose Manuel Perez-Aguilar; Jinglei Ping; A T Charlie Johnson; Jeffery G Saven; Renyu Liu
Journal:  J Biomol Struct Dyn       Date:  2019-10-17

9.  A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.

Authors:  Jose Manuel Perez-Aguilar; Jin Xi; Felipe Matsunaga; Xu Cui; Bernard Selling; Jeffery G Saven; Renyu Liu
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

10.  Expression and purification of functional human mu opioid receptor from E.coli.

Authors:  Yanbin Ma; Jan Kubicek; Jörg Labahn
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.